3-iodobenzylguanidine has been researched along with Cancer of Jejunum in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kline, G; McEwan, A; Pasieka, JL; Rorstad, O; Sywak, MS | 1 |
| Akle, CA; Bomanji, JB; Talbot, I; Wardle, DG | 1 |
| Bourguet, P; Bretagne, JF; Etienne, PL; Gosselin, M; Herry, JY; Lescouarc'h, J; Raoul, JL; Siproudhis, L | 1 |
3 other study(ies) available for 3-iodobenzylguanidine and Cancer of Jejunum
| Article | Year |
|---|---|
131I-meta-iodobenzylguanidine in the management of metastatic midgut carcinoid tumors.
Topics: 3-Iodobenzylguanidine; Aged; Antineoplastic Agents; Carcinoid Tumor; Combined Modality Therapy; Female; Humans; Ileal Neoplasms; Intestinal Neoplasms; Jejunal Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Peritoneal Neoplasms; Retrospective Studies; Survival Analysis | 2004 |
mIBG diagnosis and therapy in smooth muscle tumours of the small bowel.
Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Combined Chemotherapy Protocols; Humans; Iodine Radioisotopes; Jejunal Neoplasms; Male; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma | 1997 |
[Contribution of 131I MIBG scintigraphy in the diagnosis of carcinoid tumors of the digestive tract. Experience of 14 cases].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Carcinoid Tumor; Female; Humans; Ileal Neoplasms; Iodine Radioisotopes; Iodobenzenes; Jejunal Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Prospective Studies; Radionuclide Imaging; Rectal Neoplasms | 1991 |